ArticleNature communications2024

Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications.

Kai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.